A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently inactivated in several kinds of malignancies, resulting https://bookmarkilo.com/story21818272/mini-antibodies-revive-tumor-suppressor-p53-new-potential-pathway-for-cancer-management